DiscoveRx Corporation Expands Its GPCR Technology Portfolio to Include Advanced Technologies That Facilitate Lead Optimization and SAR  
4/8/2010 10:17:25 AM

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx continues to innovate in the field of GPCR signaling assays, tools and services with the introduction of two additional GPCR platforms to facilitate counterscreening, lead optimization and SAR evaluation of compounds identified during a primary screen.